IGF1 is the target gene of miR-18a-5p. (a) According to the bioinformatics prediction, miR-18a-5p has a putative complementary sequence in the 3′-UTR of IGF1. (b) The luciferase activity of cells in different groups. *** p < 0.001. (c) The mRNA level of IGF1 in different cell groups. ***p < 0.001, compared with control group. (d) The mRNA level of IGF1 in different cell groups. ***p < 0.001, compared with control group; #p < 0.05, ##p < 0.01, compared with CSE group. (e) The IGF1 mRNA level in different serum samples. ***p < 0.001, compared with non-smoker group; ###p < 0.01, compared with CSE group. (f) Serum miR-18a-5p showed a negative association with IGF1 level in all smokers. (g) Serum IGF1 showed a negative association with CASC2 level in all smokers. Differences between groups were compared using one-way analysis of variance.
CASC2, cancer susceptibility candidate 2; COPD, chronic obstructive pulmonary disease; CSE, cigarette smoke extract; mRNA, messager RNA; Mut, mutant type; NC, negative control; Wt, wild type.